nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP1A2—Carmustine—melanoma	0.157	0.246	CbGbCtD
Modafinil—CYP1A2—Vemurafenib—melanoma	0.124	0.194	CbGbCtD
Modafinil—CYP3A4—Temozolomide—melanoma	0.119	0.186	CbGbCtD
Modafinil—CYP1A2—Dacarbazine—melanoma	0.0952	0.149	CbGbCtD
Modafinil—CYP3A4—Vemurafenib—melanoma	0.065	0.102	CbGbCtD
Modafinil—CYP3A5—Docetaxel—melanoma	0.0572	0.0895	CbGbCtD
Modafinil—CYP3A4—Docetaxel—melanoma	0.0223	0.0349	CbGbCtD
Modafinil—Ketoprofen—CXCR1—melanoma	0.00253	0.288	CrCbGaD
Modafinil—Bifonazole—CYP17A1—melanoma	0.00129	0.146	CrCbGaD
Modafinil—Asthenia—Vemurafenib—melanoma	0.000713	0.00254	CcSEcCtD
Modafinil—Visual impairment—Carmustine—melanoma	0.000713	0.00254	CcSEcCtD
Modafinil—Hallucination—Temozolomide—melanoma	0.000711	0.00253	CcSEcCtD
Modafinil—Pharyngitis—Temozolomide—melanoma	0.000709	0.00253	CcSEcCtD
Modafinil—Chills—Dactinomycin—melanoma	0.000709	0.00253	CcSEcCtD
Modafinil—Urinary tract disorder—Temozolomide—melanoma	0.000706	0.00251	CcSEcCtD
Modafinil—Oedema peripheral—Temozolomide—melanoma	0.000704	0.00251	CcSEcCtD
Modafinil—Pruritus—Vemurafenib—melanoma	0.000703	0.0025	CcSEcCtD
Modafinil—Connective tissue disorder—Temozolomide—melanoma	0.000702	0.0025	CcSEcCtD
Modafinil—Urethral disorder—Temozolomide—melanoma	0.000701	0.0025	CcSEcCtD
Modafinil—Visual impairment—Temozolomide—melanoma	0.000689	0.00245	CcSEcCtD
Modafinil—Ill-defined disorder—Bleomycin—melanoma	0.000684	0.00244	CcSEcCtD
Modafinil—Anaemia—Bleomycin—melanoma	0.000682	0.00243	CcSEcCtD
Modafinil—Diarrhoea—Vemurafenib—melanoma	0.00068	0.00242	CcSEcCtD
Modafinil—Migraine—Docetaxel—melanoma	0.000676	0.00241	CcSEcCtD
Modafinil—Erythema multiforme—Temozolomide—melanoma	0.000676	0.00241	CcSEcCtD
Modafinil—Malaise—Bleomycin—melanoma	0.000665	0.00237	CcSEcCtD
Modafinil—Cardiac disorder—Temozolomide—melanoma	0.000663	0.00236	CcSEcCtD
Modafinil—Arrhythmia—Carmustine—melanoma	0.000661	0.00235	CcSEcCtD
Modafinil—Dizziness—Vemurafenib—melanoma	0.000657	0.00234	CcSEcCtD
Modafinil—Angiopathy—Temozolomide—melanoma	0.000648	0.00231	CcSEcCtD
Modafinil—Mental disorder—Carmustine—melanoma	0.000648	0.00231	CcSEcCtD
Modafinil—Ataxia—Docetaxel—melanoma	0.000646	0.0023	CcSEcCtD
Modafinil—Immune system disorder—Temozolomide—melanoma	0.000645	0.0023	CcSEcCtD
Modafinil—Mediastinal disorder—Temozolomide—melanoma	0.000644	0.00229	CcSEcCtD
Modafinil—Malnutrition—Carmustine—melanoma	0.000644	0.00229	CcSEcCtD
Modafinil—Cough—Bleomycin—melanoma	0.000644	0.00229	CcSEcCtD
Modafinil—Chills—Temozolomide—melanoma	0.000641	0.00228	CcSEcCtD
Modafinil—Ketoprofen—CXCL8—melanoma	0.000638	0.0727	CrCbGaD
Modafinil—Ill-defined disorder—Dactinomycin—melanoma	0.000638	0.00227	CcSEcCtD
Modafinil—Anaemia—Dactinomycin—melanoma	0.000636	0.00226	CcSEcCtD
Modafinil—Vomiting—Vemurafenib—melanoma	0.000632	0.00225	CcSEcCtD
Modafinil—Dry skin—Docetaxel—melanoma	0.00063	0.00224	CcSEcCtD
Modafinil—Chest pain—Bleomycin—melanoma	0.000628	0.00224	CcSEcCtD
Modafinil—Myalgia—Bleomycin—melanoma	0.000628	0.00224	CcSEcCtD
Modafinil—Abdominal pain upper—Docetaxel—melanoma	0.000627	0.00224	CcSEcCtD
Modafinil—Rash—Vemurafenib—melanoma	0.000626	0.00223	CcSEcCtD
Modafinil—Mental disorder—Temozolomide—melanoma	0.000626	0.00223	CcSEcCtD
Modafinil—Dermatitis—Vemurafenib—melanoma	0.000626	0.00223	CcSEcCtD
Modafinil—Back pain—Carmustine—melanoma	0.000623	0.00222	CcSEcCtD
Modafinil—Headache—Vemurafenib—melanoma	0.000622	0.00222	CcSEcCtD
Modafinil—Malnutrition—Temozolomide—melanoma	0.000622	0.00222	CcSEcCtD
Modafinil—Discomfort—Bleomycin—melanoma	0.00062	0.00221	CcSEcCtD
Modafinil—Malaise—Dactinomycin—melanoma	0.00062	0.00221	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000619	0.0022	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000619	0.0022	CcSEcCtD
Modafinil—Dysgeusia—Temozolomide—melanoma	0.000609	0.00217	CcSEcCtD
Modafinil—Confusional state—Bleomycin—melanoma	0.000607	0.00216	CcSEcCtD
Modafinil—Tremor—Carmustine—melanoma	0.000603	0.00215	CcSEcCtD
Modafinil—Anaphylactic shock—Bleomycin—melanoma	0.000602	0.00214	CcSEcCtD
Modafinil—Oedema—Bleomycin—melanoma	0.000602	0.00214	CcSEcCtD
Modafinil—Back pain—Temozolomide—melanoma	0.000602	0.00214	CcSEcCtD
Modafinil—Infection—Bleomycin—melanoma	0.000598	0.00213	CcSEcCtD
Modafinil—Anaemia—Carmustine—melanoma	0.000595	0.00212	CcSEcCtD
Modafinil—Agitation—Carmustine—melanoma	0.000592	0.00211	CcSEcCtD
Modafinil—Nausea—Vemurafenib—melanoma	0.00059	0.0021	CcSEcCtD
Modafinil—Myalgia—Dactinomycin—melanoma	0.000586	0.00209	CcSEcCtD
Modafinil—Tremor—Temozolomide—melanoma	0.000583	0.00208	CcSEcCtD
Modafinil—Discomfort—Dactinomycin—melanoma	0.000579	0.00206	CcSEcCtD
Modafinil—Ill-defined disorder—Temozolomide—melanoma	0.000577	0.00206	CcSEcCtD
Modafinil—Anaemia—Temozolomide—melanoma	0.000575	0.00205	CcSEcCtD
Modafinil—Anorexia—Bleomycin—melanoma	0.000574	0.00204	CcSEcCtD
Modafinil—Agitation—Temozolomide—melanoma	0.000572	0.00204	CcSEcCtD
Modafinil—Angioedema—Temozolomide—melanoma	0.000568	0.00203	CcSEcCtD
Modafinil—Pancytopenia—Docetaxel—melanoma	0.000564	0.00201	CcSEcCtD
Modafinil—Hypotension—Bleomycin—melanoma	0.000562	0.002	CcSEcCtD
Modafinil—Oedema—Dactinomycin—melanoma	0.000561	0.002	CcSEcCtD
Modafinil—Malaise—Temozolomide—melanoma	0.000561	0.002	CcSEcCtD
Modafinil—Vertigo—Temozolomide—melanoma	0.000559	0.00199	CcSEcCtD
Modafinil—Convulsion—Carmustine—melanoma	0.000558	0.00199	CcSEcCtD
Modafinil—Infection—Dactinomycin—melanoma	0.000558	0.00199	CcSEcCtD
Modafinil—Hypertension—Carmustine—melanoma	0.000556	0.00198	CcSEcCtD
Modafinil—Palpitations—Temozolomide—melanoma	0.00055	0.00196	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Bleomycin—melanoma	0.000548	0.00195	CcSEcCtD
Modafinil—Chest pain—Carmustine—melanoma	0.000548	0.00195	CcSEcCtD
Modafinil—Myalgia—Carmustine—melanoma	0.000548	0.00195	CcSEcCtD
Modafinil—Anxiety—Carmustine—melanoma	0.000546	0.00195	CcSEcCtD
Modafinil—Cough—Temozolomide—melanoma	0.000543	0.00193	CcSEcCtD
Modafinil—Paraesthesia—Bleomycin—melanoma	0.00054	0.00193	CcSEcCtD
Modafinil—Weight increased—Docetaxel—melanoma	0.00054	0.00192	CcSEcCtD
Modafinil—Convulsion—Temozolomide—melanoma	0.000539	0.00192	CcSEcCtD
Modafinil—Weight decreased—Docetaxel—melanoma	0.000537	0.00191	CcSEcCtD
Modafinil—Hypertension—Temozolomide—melanoma	0.000537	0.00191	CcSEcCtD
Modafinil—Dyspnoea—Bleomycin—melanoma	0.000537	0.00191	CcSEcCtD
Modafinil—Anorexia—Dactinomycin—melanoma	0.000535	0.00191	CcSEcCtD
Modafinil—Pneumonia—Docetaxel—melanoma	0.000532	0.0019	CcSEcCtD
Modafinil—Confusional state—Carmustine—melanoma	0.00053	0.00189	CcSEcCtD
Modafinil—Myalgia—Temozolomide—melanoma	0.00053	0.00189	CcSEcCtD
Modafinil—Arthralgia—Temozolomide—melanoma	0.00053	0.00189	CcSEcCtD
Modafinil—Anxiety—Temozolomide—melanoma	0.000528	0.00188	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000526	0.00187	CcSEcCtD
Modafinil—Oedema—Carmustine—melanoma	0.000525	0.00187	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000525	0.00187	CcSEcCtD
Modafinil—Discomfort—Temozolomide—melanoma	0.000523	0.00186	CcSEcCtD
Modafinil—Decreased appetite—Bleomycin—melanoma	0.000523	0.00186	CcSEcCtD
Modafinil—Infection—Carmustine—melanoma	0.000522	0.00186	CcSEcCtD
Modafinil—Dry mouth—Temozolomide—melanoma	0.000518	0.00185	CcSEcCtD
Modafinil—Stomatitis—Docetaxel—melanoma	0.000516	0.00184	CcSEcCtD
Modafinil—Pain—Bleomycin—melanoma	0.000515	0.00183	CcSEcCtD
Modafinil—Conjunctivitis—Docetaxel—melanoma	0.000515	0.00183	CcSEcCtD
Modafinil—Tachycardia—Carmustine—melanoma	0.000513	0.00183	CcSEcCtD
Modafinil—Confusional state—Temozolomide—melanoma	0.000512	0.00182	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000511	0.00182	CcSEcCtD
Modafinil—Oedema—Temozolomide—melanoma	0.000508	0.00181	CcSEcCtD
Modafinil—Anaphylactic shock—Temozolomide—melanoma	0.000508	0.00181	CcSEcCtD
Modafinil—Infection—Temozolomide—melanoma	0.000504	0.0018	CcSEcCtD
Modafinil—Orphenadrine—SCN10A—melanoma	0.000503	0.0573	CrCbGaD
Modafinil—Anorexia—Carmustine—melanoma	0.000501	0.00178	CcSEcCtD
Modafinil—Epistaxis—Docetaxel—melanoma	0.000499	0.00178	CcSEcCtD
Modafinil—Nervous system disorder—Temozolomide—melanoma	0.000498	0.00177	CcSEcCtD
Modafinil—Feeling abnormal—Bleomycin—melanoma	0.000496	0.00177	CcSEcCtD
Modafinil—Agranulocytosis—Docetaxel—melanoma	0.000494	0.00176	CcSEcCtD
Modafinil—Skin disorder—Temozolomide—melanoma	0.000493	0.00176	CcSEcCtD
Modafinil—Hypotension—Carmustine—melanoma	0.000491	0.00175	CcSEcCtD
Modafinil—Hyperhidrosis—Temozolomide—melanoma	0.000491	0.00175	CcSEcCtD
Modafinil—Decreased appetite—Dactinomycin—melanoma	0.000488	0.00174	CcSEcCtD
Modafinil—Fatigue—Dactinomycin—melanoma	0.000484	0.00172	CcSEcCtD
Modafinil—Anorexia—Temozolomide—melanoma	0.000484	0.00172	CcSEcCtD
Modafinil—Pain—Dactinomycin—melanoma	0.00048	0.00171	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Carmustine—melanoma	0.000479	0.00171	CcSEcCtD
Modafinil—Urticaria—Bleomycin—melanoma	0.000478	0.0017	CcSEcCtD
Modafinil—Rhinitis—Docetaxel—melanoma	0.000476	0.0017	CcSEcCtD
Modafinil—Body temperature increased—Bleomycin—melanoma	0.000476	0.0017	CcSEcCtD
Modafinil—Insomnia—Carmustine—melanoma	0.000475	0.00169	CcSEcCtD
Modafinil—Paraesthesia—Carmustine—melanoma	0.000472	0.00168	CcSEcCtD
Modafinil—Pharyngitis—Docetaxel—melanoma	0.000472	0.00168	CcSEcCtD
Modafinil—Urinary tract disorder—Docetaxel—melanoma	0.000469	0.00167	CcSEcCtD
Modafinil—Dyspnoea—Carmustine—melanoma	0.000468	0.00167	CcSEcCtD
Modafinil—Oedema peripheral—Docetaxel—melanoma	0.000468	0.00167	CcSEcCtD
Modafinil—Somnolence—Carmustine—melanoma	0.000467	0.00166	CcSEcCtD
Modafinil—Connective tissue disorder—Docetaxel—melanoma	0.000467	0.00166	CcSEcCtD
Modafinil—Urethral disorder—Docetaxel—melanoma	0.000466	0.00166	CcSEcCtD
Modafinil—Feeling abnormal—Dactinomycin—melanoma	0.000463	0.00165	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Temozolomide—melanoma	0.000463	0.00165	CcSEcCtD
Modafinil—Nepafenac—PTGS2—melanoma	0.000459	0.0523	CrCbGaD
Modafinil—Insomnia—Temozolomide—melanoma	0.000459	0.00164	CcSEcCtD
Modafinil—Gastrointestinal pain—Dactinomycin—melanoma	0.000459	0.00164	CcSEcCtD
Modafinil—Visual impairment—Docetaxel—melanoma	0.000458	0.00163	CcSEcCtD
Modafinil—Decreased appetite—Carmustine—melanoma	0.000457	0.00163	CcSEcCtD
Modafinil—Paraesthesia—Temozolomide—melanoma	0.000456	0.00162	CcSEcCtD
Modafinil—Gastrointestinal disorder—Carmustine—melanoma	0.000454	0.00162	CcSEcCtD
Modafinil—Dyspnoea—Temozolomide—melanoma	0.000453	0.00161	CcSEcCtD
Modafinil—Somnolence—Temozolomide—melanoma	0.000451	0.00161	CcSEcCtD
Modafinil—Erythema multiforme—Docetaxel—melanoma	0.000449	0.0016	CcSEcCtD
Modafinil—Pain—Carmustine—melanoma	0.000449	0.0016	CcSEcCtD
Modafinil—Constipation—Carmustine—melanoma	0.000449	0.0016	CcSEcCtD
Modafinil—Dyspepsia—Temozolomide—melanoma	0.000447	0.00159	CcSEcCtD
Modafinil—Body temperature increased—Dactinomycin—melanoma	0.000444	0.00158	CcSEcCtD
Modafinil—Abdominal pain—Dactinomycin—melanoma	0.000444	0.00158	CcSEcCtD
Modafinil—Hypersensitivity—Bleomycin—melanoma	0.000443	0.00158	CcSEcCtD
Modafinil—Decreased appetite—Temozolomide—melanoma	0.000441	0.00157	CcSEcCtD
Modafinil—Cardiac disorder—Docetaxel—melanoma	0.000441	0.00157	CcSEcCtD
Modafinil—Gastrointestinal disorder—Temozolomide—melanoma	0.000438	0.00156	CcSEcCtD
Modafinil—Fatigue—Temozolomide—melanoma	0.000438	0.00156	CcSEcCtD
Modafinil—Pain—Temozolomide—melanoma	0.000434	0.00155	CcSEcCtD
Modafinil—Constipation—Temozolomide—melanoma	0.000434	0.00155	CcSEcCtD
Modafinil—Feeling abnormal—Carmustine—melanoma	0.000433	0.00154	CcSEcCtD
Modafinil—Asthenia—Bleomycin—melanoma	0.000432	0.00154	CcSEcCtD
Modafinil—Angiopathy—Docetaxel—melanoma	0.000431	0.00154	CcSEcCtD
Modafinil—Gastrointestinal pain—Carmustine—melanoma	0.00043	0.00153	CcSEcCtD
Modafinil—Immune system disorder—Docetaxel—melanoma	0.000429	0.00153	CcSEcCtD
Modafinil—Mediastinal disorder—Docetaxel—melanoma	0.000428	0.00153	CcSEcCtD
Modafinil—Chills—Docetaxel—melanoma	0.000426	0.00152	CcSEcCtD
Modafinil—Pruritus—Bleomycin—melanoma	0.000426	0.00152	CcSEcCtD
Modafinil—Arrhythmia—Docetaxel—melanoma	0.000425	0.00151	CcSEcCtD
Modafinil—Feeling abnormal—Temozolomide—melanoma	0.000418	0.00149	CcSEcCtD
Modafinil—Mental disorder—Docetaxel—melanoma	0.000416	0.00148	CcSEcCtD
Modafinil—Body temperature increased—Carmustine—melanoma	0.000415	0.00148	CcSEcCtD
Modafinil—Abdominal pain—Carmustine—melanoma	0.000415	0.00148	CcSEcCtD
Modafinil—Gastrointestinal pain—Temozolomide—melanoma	0.000415	0.00148	CcSEcCtD
Modafinil—Malnutrition—Docetaxel—melanoma	0.000414	0.00147	CcSEcCtD
Modafinil—Hypersensitivity—Dactinomycin—melanoma	0.000414	0.00147	CcSEcCtD
Modafinil—Dysgeusia—Docetaxel—melanoma	0.000405	0.00144	CcSEcCtD
Modafinil—Urticaria—Temozolomide—melanoma	0.000403	0.00144	CcSEcCtD
Modafinil—Asthenia—Dactinomycin—melanoma	0.000403	0.00143	CcSEcCtD
Modafinil—Body temperature increased—Temozolomide—melanoma	0.000401	0.00143	CcSEcCtD
Modafinil—Abdominal pain—Temozolomide—melanoma	0.000401	0.00143	CcSEcCtD
Modafinil—Back pain—Docetaxel—melanoma	0.0004	0.00143	CcSEcCtD
Modafinil—Muscle spasms—Docetaxel—melanoma	0.000398	0.00142	CcSEcCtD
Modafinil—Hypersensitivity—Carmustine—melanoma	0.000387	0.00138	CcSEcCtD
Modafinil—Diarrhoea—Dactinomycin—melanoma	0.000384	0.00137	CcSEcCtD
Modafinil—Vomiting—Bleomycin—melanoma	0.000383	0.00136	CcSEcCtD
Modafinil—Anaemia—Docetaxel—melanoma	0.000382	0.00136	CcSEcCtD
Modafinil—Oxaprozin—PTGS2—melanoma	0.000382	0.0435	CrCbGaD
Modafinil—Rash—Bleomycin—melanoma	0.000379	0.00135	CcSEcCtD
Modafinil—Dermatitis—Bleomycin—melanoma	0.000379	0.00135	CcSEcCtD
Modafinil—Asthenia—Carmustine—melanoma	0.000377	0.00134	CcSEcCtD
Modafinil—Hypersensitivity—Temozolomide—melanoma	0.000374	0.00133	CcSEcCtD
Modafinil—Syncope—Docetaxel—melanoma	0.000371	0.00132	CcSEcCtD
Modafinil—Palpitations—Docetaxel—melanoma	0.000366	0.0013	CcSEcCtD
Modafinil—Asthenia—Temozolomide—melanoma	0.000364	0.0013	CcSEcCtD
Modafinil—Loss of consciousness—Docetaxel—melanoma	0.000364	0.0013	CcSEcCtD
Modafinil—Cough—Docetaxel—melanoma	0.000361	0.00129	CcSEcCtD
Modafinil—Diarrhoea—Carmustine—melanoma	0.000359	0.00128	CcSEcCtD
Modafinil—Pruritus—Temozolomide—melanoma	0.000359	0.00128	CcSEcCtD
Modafinil—Convulsion—Docetaxel—melanoma	0.000358	0.00128	CcSEcCtD
Modafinil—Nausea—Bleomycin—melanoma	0.000358	0.00127	CcSEcCtD
Modafinil—Hypertension—Docetaxel—melanoma	0.000357	0.00127	CcSEcCtD
Modafinil—Vomiting—Dactinomycin—melanoma	0.000357	0.00127	CcSEcCtD
Modafinil—Rash—Dactinomycin—melanoma	0.000354	0.00126	CcSEcCtD
Modafinil—Fosphenytoin—ALB—melanoma	0.000354	0.0403	CrCbGaD
Modafinil—Chest pain—Docetaxel—melanoma	0.000352	0.00125	CcSEcCtD
Modafinil—Myalgia—Docetaxel—melanoma	0.000352	0.00125	CcSEcCtD
Modafinil—Arthralgia—Docetaxel—melanoma	0.000352	0.00125	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00035	0.00125	CcSEcCtD
Modafinil—Dizziness—Carmustine—melanoma	0.000347	0.00124	CcSEcCtD
Modafinil—Diarrhoea—Temozolomide—melanoma	0.000347	0.00124	CcSEcCtD
Modafinil—Dry mouth—Docetaxel—melanoma	0.000344	0.00123	CcSEcCtD
Modafinil—Confusional state—Docetaxel—melanoma	0.00034	0.00121	CcSEcCtD
Modafinil—Oedema—Docetaxel—melanoma	0.000338	0.0012	CcSEcCtD
Modafinil—Anaphylactic shock—Docetaxel—melanoma	0.000338	0.0012	CcSEcCtD
Modafinil—Dizziness—Temozolomide—melanoma	0.000336	0.0012	CcSEcCtD
Modafinil—Infection—Docetaxel—melanoma	0.000335	0.00119	CcSEcCtD
Modafinil—Vomiting—Carmustine—melanoma	0.000334	0.00119	CcSEcCtD
Modafinil—Nausea—Dactinomycin—melanoma	0.000333	0.00119	CcSEcCtD
Modafinil—Shock—Docetaxel—melanoma	0.000332	0.00118	CcSEcCtD
Modafinil—Rash—Carmustine—melanoma	0.000331	0.00118	CcSEcCtD
Modafinil—Nervous system disorder—Docetaxel—melanoma	0.000331	0.00118	CcSEcCtD
Modafinil—Dermatitis—Carmustine—melanoma	0.000331	0.00118	CcSEcCtD
Modafinil—Tachycardia—Docetaxel—melanoma	0.00033	0.00117	CcSEcCtD
Modafinil—Headache—Carmustine—melanoma	0.000329	0.00117	CcSEcCtD
Modafinil—Skin disorder—Docetaxel—melanoma	0.000328	0.00117	CcSEcCtD
Modafinil—Vomiting—Temozolomide—melanoma	0.000323	0.00115	CcSEcCtD
Modafinil—Anorexia—Docetaxel—melanoma	0.000322	0.00115	CcSEcCtD
Modafinil—Rash—Temozolomide—melanoma	0.00032	0.00114	CcSEcCtD
Modafinil—Dermatitis—Temozolomide—melanoma	0.00032	0.00114	CcSEcCtD
Modafinil—Headache—Temozolomide—melanoma	0.000318	0.00113	CcSEcCtD
Modafinil—Hypotension—Docetaxel—melanoma	0.000315	0.00112	CcSEcCtD
Modafinil—Fenoprofen—PTGS2—melanoma	0.000315	0.0359	CrCbGaD
Modafinil—Nausea—Carmustine—melanoma	0.000312	0.00111	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Docetaxel—melanoma	0.000308	0.0011	CcSEcCtD
Modafinil—Insomnia—Docetaxel—melanoma	0.000305	0.00109	CcSEcCtD
Modafinil—Paraesthesia—Docetaxel—melanoma	0.000303	0.00108	CcSEcCtD
Modafinil—Nausea—Temozolomide—melanoma	0.000302	0.00107	CcSEcCtD
Modafinil—Dyspnoea—Docetaxel—melanoma	0.000301	0.00107	CcSEcCtD
Modafinil—Somnolence—Docetaxel—melanoma	0.0003	0.00107	CcSEcCtD
Modafinil—Dyspepsia—Docetaxel—melanoma	0.000297	0.00106	CcSEcCtD
Modafinil—Decreased appetite—Docetaxel—melanoma	0.000294	0.00105	CcSEcCtD
Modafinil—Gastrointestinal disorder—Docetaxel—melanoma	0.000291	0.00104	CcSEcCtD
Modafinil—Fatigue—Docetaxel—melanoma	0.000291	0.00104	CcSEcCtD
Modafinil—Pain—Docetaxel—melanoma	0.000289	0.00103	CcSEcCtD
Modafinil—Constipation—Docetaxel—melanoma	0.000289	0.00103	CcSEcCtD
Modafinil—Fenoprofen—ALB—melanoma	0.000281	0.032	CrCbGaD
Modafinil—Feeling abnormal—Docetaxel—melanoma	0.000278	0.000991	CcSEcCtD
Modafinil—Gastrointestinal pain—Docetaxel—melanoma	0.000276	0.000984	CcSEcCtD
Modafinil—Abdominal pain—Docetaxel—melanoma	0.000267	0.000951	CcSEcCtD
Modafinil—Body temperature increased—Docetaxel—melanoma	0.000267	0.000951	CcSEcCtD
Modafinil—Phenylbutazone—PTGS2—melanoma	0.000252	0.0287	CrCbGaD
Modafinil—Hypersensitivity—Docetaxel—melanoma	0.000249	0.000886	CcSEcCtD
Modafinil—Phenprocoumon—ALB—melanoma	0.000242	0.0276	CrCbGaD
Modafinil—Asthenia—Docetaxel—melanoma	0.000242	0.000863	CcSEcCtD
Modafinil—Pruritus—Docetaxel—melanoma	0.000239	0.000851	CcSEcCtD
Modafinil—Oxcarbazepine—ALB—melanoma	0.000236	0.0269	CrCbGaD
Modafinil—Diarrhoea—Docetaxel—melanoma	0.000231	0.000823	CcSEcCtD
Modafinil—Dizziness—Docetaxel—melanoma	0.000223	0.000795	CcSEcCtD
Modafinil—Warfarin—ALB—melanoma	0.000215	0.0245	CrCbGaD
Modafinil—Vomiting—Docetaxel—melanoma	0.000215	0.000765	CcSEcCtD
Modafinil—Rash—Docetaxel—melanoma	0.000213	0.000758	CcSEcCtD
Modafinil—Dermatitis—Docetaxel—melanoma	0.000213	0.000758	CcSEcCtD
Modafinil—Headache—Docetaxel—melanoma	0.000212	0.000754	CcSEcCtD
Modafinil—Nausea—Docetaxel—melanoma	0.000201	0.000714	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—melanoma	0.000186	0.0212	CrCbGaD
Modafinil—Ketoprofen—ALB—melanoma	0.000166	0.0189	CrCbGaD
Modafinil—Fentanyl—ABCB1—melanoma	0.000164	0.0187	CrCbGaD
Modafinil—Phenytoin—ALB—melanoma	0.000156	0.0178	CrCbGaD
Modafinil—Carbamazepine—ABCB1—melanoma	0.000153	0.0175	CrCbGaD
Modafinil—Phenytoin—ABCB1—melanoma	0.000149	0.017	CrCbGaD
Modafinil—Methadone—ABCB1—melanoma	0.000113	0.0128	CrCbGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CG—melanoma	1.99e-05	0.000281	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP17A1—melanoma	1.98e-05	0.000279	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PLA2G6—melanoma	1.97e-05	0.000279	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HPSE—melanoma	1.97e-05	0.000278	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP17A1—melanoma	1.93e-05	0.000273	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CUBN—melanoma	1.93e-05	0.000273	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PLCB4—melanoma	1.9e-05	0.000268	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HDAC2—melanoma	1.9e-05	0.000268	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FOXO4—melanoma	1.9e-05	0.000268	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCR4—melanoma	1.9e-05	0.000268	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GNAQ—melanoma	1.88e-05	0.000265	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GNA11—melanoma	1.87e-05	0.000264	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CSPG4—melanoma	1.87e-05	0.000264	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BSG—melanoma	1.87e-05	0.000264	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SDHD—melanoma	1.87e-05	0.000264	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—FASN—melanoma	1.83e-05	0.000258	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GNA11—melanoma	1.83e-05	0.000258	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CG—melanoma	1.81e-05	0.000255	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPAM—melanoma	1.81e-05	0.000255	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PLA2G6—melanoma	1.8e-05	0.000254	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SLC5A5—melanoma	1.8e-05	0.000254	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC6A11—melanoma	1.79e-05	0.000252	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIP4K2A—melanoma	1.79e-05	0.000252	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—FASN—melanoma	1.79e-05	0.000252	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—VCAN—melanoma	1.77e-05	0.00025	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SYK—melanoma	1.77e-05	0.000249	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SLC5A5—melanoma	1.76e-05	0.000248	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CD—melanoma	1.75e-05	0.000247	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTAP—melanoma	1.74e-05	0.000246	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GNAQ—melanoma	1.74e-05	0.000245	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CD44—melanoma	1.74e-05	0.000245	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ITGAV—melanoma	1.73e-05	0.000245	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT3—melanoma	1.73e-05	0.000245	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NGFR—melanoma	1.73e-05	0.000245	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GNAQ—melanoma	1.7e-05	0.00024	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CD44—melanoma	1.7e-05	0.00024	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.68e-05	0.000237	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1B1—melanoma	1.67e-05	0.000235	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1B1—melanoma	1.63e-05	0.00023	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.62e-05	0.000229	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—VCAN—melanoma	1.62e-05	0.000228	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SOCS1—melanoma	1.6e-05	0.000227	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAP2K1—melanoma	1.6e-05	0.000226	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—S100B—melanoma	1.6e-05	0.000226	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CD—melanoma	1.59e-05	0.000225	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LUM—melanoma	1.55e-05	0.000219	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PHGDH—melanoma	1.55e-05	0.000219	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PLA2G6—melanoma	1.54e-05	0.000217	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB4—melanoma	1.53e-05	0.000216	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.53e-05	0.000216	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CB—melanoma	1.53e-05	0.000216	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HPSE—melanoma	1.52e-05	0.000215	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN2B—melanoma	1.52e-05	0.000214	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP17A1—melanoma	1.5e-05	0.000211	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CUBN—melanoma	1.49e-05	0.000211	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.48e-05	0.000208	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.47e-05	0.000208	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CD86—melanoma	1.47e-05	0.000207	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCL8—melanoma	1.47e-05	0.000207	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.46e-05	0.000206	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EDN1—melanoma	1.46e-05	0.000206	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SDHD—melanoma	1.44e-05	0.000203	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BSG—melanoma	1.44e-05	0.000203	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CSPG4—melanoma	1.44e-05	0.000203	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CSF2—melanoma	1.42e-05	0.000201	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGF1—melanoma	1.42e-05	0.000201	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GNA11—melanoma	1.41e-05	0.000199	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2—melanoma	1.4e-05	0.000198	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPAM—melanoma	1.4e-05	0.000197	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—E2F1—melanoma	1.39e-05	0.000197	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CB—melanoma	1.39e-05	0.000196	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—FASN—melanoma	1.38e-05	0.000195	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—VCAN—melanoma	1.38e-05	0.000195	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PDGFRA—melanoma	1.38e-05	0.000195	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ABCB1—melanoma	1.37e-05	0.000194	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ITGB3—melanoma	1.36e-05	0.000193	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PRKCA—melanoma	1.36e-05	0.000193	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP17A1—melanoma	1.36e-05	0.000193	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC5A5—melanoma	1.36e-05	0.000192	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.34e-05	0.00019	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ABCB1—melanoma	1.34e-05	0.000189	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SPP1—melanoma	1.34e-05	0.000189	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAP2K2—melanoma	1.33e-05	0.000188	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCL8—melanoma	1.33e-05	0.000188	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.33e-05	0.000187	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GNAQ—melanoma	1.31e-05	0.000185	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CD44—melanoma	1.31e-05	0.000185	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.31e-05	0.000185	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GNA11—melanoma	1.29e-05	0.000182	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.29e-05	0.000182	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.27e-05	0.00018	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2—melanoma	1.27e-05	0.00018	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TERT—melanoma	1.27e-05	0.000179	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RAC1—melanoma	1.26e-05	0.000179	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PRKCA—melanoma	1.26e-05	0.000178	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.26e-05	0.000178	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—FASN—melanoma	1.26e-05	0.000178	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1B1—melanoma	1.26e-05	0.000178	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ERCC2—melanoma	1.25e-05	0.000177	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC5A5—melanoma	1.24e-05	0.000175	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PRKCA—melanoma	1.23e-05	0.000174	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ERCC2—melanoma	1.22e-05	0.000173	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HIF1A—melanoma	1.21e-05	0.000171	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CD44—melanoma	1.2e-05	0.000169	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GNAQ—melanoma	1.2e-05	0.000169	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PLA2G6—melanoma	1.19e-05	0.000168	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.17e-05	0.000166	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP17A1—melanoma	1.17e-05	0.000165	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.16e-05	0.000164	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KDR—melanoma	1.16e-05	0.000164	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.15e-05	0.000162	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1B1—melanoma	1.15e-05	0.000162	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.13e-05	0.00016	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FN1—melanoma	1.12e-05	0.000158	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.11e-05	0.000157	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GNA11—melanoma	1.1e-05	0.000155	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOTCH1—melanoma	1.09e-05	0.000154	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—FASN—melanoma	1.08e-05	0.000152	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CD80—melanoma	1.07e-05	0.000151	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CG—melanoma	1.07e-05	0.000151	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APC—melanoma	1.07e-05	0.000151	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KIT—melanoma	1.07e-05	0.000151	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—NRAS—melanoma	1.07e-05	0.000151	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—VCAN—melanoma	1.07e-05	0.000151	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC5A5—melanoma	1.06e-05	0.00015	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGF—melanoma	1.06e-05	0.000149	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCB1—melanoma	1.04e-05	0.000146	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK3—melanoma	1.02e-05	0.000145	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GNAQ—melanoma	1.02e-05	0.000144	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CD44—melanoma	1.02e-05	0.000144	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.01e-05	0.000143	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BRAF—melanoma	1e-05	0.000142	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1e-05	0.000141	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.92e-06	0.00014	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CG—melanoma	9.89e-06	0.00014	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1B1—melanoma	9.81e-06	0.000138	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF1—melanoma	9.78e-06	0.000138	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK1—melanoma	9.74e-06	0.000137	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—melanoma	9.73e-06	0.000137	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CG—melanoma	9.66e-06	0.000136	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARG—melanoma	9.54e-06	0.000135	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PRKCA—melanoma	9.54e-06	0.000135	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ERCC2—melanoma	9.46e-06	0.000134	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAP2K1—melanoma	9.45e-06	0.000134	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCB1—melanoma	9.45e-06	0.000133	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CD—melanoma	9.39e-06	0.000133	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARG—melanoma	9.33e-06	0.000132	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—melanoma	9.3e-06	0.000131	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—KRAS—melanoma	9.2e-06	0.00013	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGF2—melanoma	8.99e-06	0.000127	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP17A1—melanoma	8.99e-06	0.000127	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PRKCA—melanoma	8.7e-06	0.000123	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CD—melanoma	8.69e-06	0.000123	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.65e-06	0.000122	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ERCC2—melanoma	8.63e-06	0.000122	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—melanoma	8.58e-06	0.000121	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CD—melanoma	8.5e-06	0.00012	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GNA11—melanoma	8.49e-06	0.00012	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—melanoma	8.45e-06	0.000119	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MDM2—melanoma	8.41e-06	0.000119	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—melanoma	8.39e-06	0.000118	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—FASN—melanoma	8.31e-06	0.000117	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB2—melanoma	8.3e-06	0.000117	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CB—melanoma	8.19e-06	0.000116	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC5A5—melanoma	8.17e-06	0.000115	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCB1—melanoma	8.08e-06	0.000114	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GNAQ—melanoma	7.89e-06	0.000111	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CD44—melanoma	7.89e-06	0.000111	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL8—melanoma	7.87e-06	0.000111	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.84e-06	0.000111	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—HRAS—melanoma	7.82e-06	0.00011	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1B—melanoma	7.68e-06	0.000108	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—melanoma	7.6e-06	0.000107	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CB—melanoma	7.58e-06	0.000107	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1B1—melanoma	7.57e-06	0.000107	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP3—melanoma	7.53e-06	0.000106	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—melanoma	7.52e-06	0.000106	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—melanoma	7.51e-06	0.000106	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—melanoma	7.48e-06	0.000106	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CG—melanoma	7.47e-06	0.000106	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PRKCA—melanoma	7.43e-06	0.000105	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CB—melanoma	7.4e-06	0.000105	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ERCC2—melanoma	7.37e-06	0.000104	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—melanoma	7.34e-06	0.000104	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCND1—melanoma	7.33e-06	0.000104	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CTNNB1—melanoma	7.26e-06	0.000103	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARG—melanoma	7.21e-06	0.000102	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.15e-06	0.000101	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—melanoma	7.12e-06	0.0001	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1A—melanoma	7.09e-06	0.0001	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTEN—melanoma	7.07e-06	9.99e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NFKB1—melanoma	7.04e-06	9.94e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—melanoma	6.9e-06	9.75e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CG—melanoma	6.81e-06	9.62e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARG—melanoma	6.57e-06	9.28e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CD—melanoma	6.57e-06	9.28e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTEN—melanoma	6.55e-06	9.24e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—melanoma	6.48e-06	9.16e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTEN—melanoma	6.4e-06	9.04e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—melanoma	6.39e-06	9.02e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—melanoma	6.33e-06	8.93e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NRAS—melanoma	6.31e-06	8.91e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCB1—melanoma	6.23e-06	8.8e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.11e-06	8.62e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK3—melanoma	6.04e-06	8.54e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CD—melanoma	5.99e-06	8.46e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—melanoma	5.91e-06	8.35e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—melanoma	5.88e-06	8.3e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CG—melanoma	5.82e-06	8.22e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK1—melanoma	5.75e-06	8.12e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—melanoma	5.75e-06	8.12e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PRKCA—melanoma	5.74e-06	8.1e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CB—melanoma	5.72e-06	8.08e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ERCC2—melanoma	5.69e-06	8.03e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—melanoma	5.67e-06	8.01e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARG—melanoma	5.62e-06	7.93e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KRAS—melanoma	5.43e-06	7.67e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CB—melanoma	5.22e-06	7.37e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—melanoma	5.17e-06	7.3e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CD—melanoma	5.12e-06	7.23e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—melanoma	5.05e-06	7.13e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—melanoma	4.99e-06	7.05e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTEN—melanoma	4.95e-06	6.99e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—melanoma	4.83e-06	6.82e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—melanoma	4.62e-06	6.52e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HRAS—melanoma	4.62e-06	6.52e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—melanoma	4.51e-06	6.37e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTEN—melanoma	4.51e-06	6.37e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CG—melanoma	4.49e-06	6.34e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CB—melanoma	4.46e-06	6.3e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—melanoma	4.42e-06	6.24e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—melanoma	4.42e-06	6.24e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARG—melanoma	4.34e-06	6.12e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—melanoma	4.08e-06	5.76e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CD—melanoma	3.95e-06	5.58e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—melanoma	3.9e-06	5.51e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTEN—melanoma	3.85e-06	5.44e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—melanoma	3.77e-06	5.33e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—melanoma	3.69e-06	5.21e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—melanoma	3.49e-06	4.93e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CB—melanoma	3.44e-06	4.86e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—melanoma	3.41e-06	4.82e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—melanoma	3.18e-06	4.49e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTEN—melanoma	2.97e-06	4.2e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—melanoma	2.85e-06	4.03e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—melanoma	2.72e-06	3.84e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—melanoma	2.6e-06	3.67e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—melanoma	2.22e-06	3.14e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—melanoma	2.1e-06	2.96e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—melanoma	1.71e-06	2.42e-05	CbGpPWpGaD
